Actinium Pharmaceuticals, Inc.
ATNM
$1.24
$0.010.81%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 127.56% | 48.43% | 11.39% | 15.44% | 3.72% |
| Total Depreciation and Amortization | 7.12% | 4.50% | 1.23% | 1.61% | 1.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -399.30% | -97.44% | 73.66% | 107.00% | 152.41% |
| Change in Net Operating Assets | 95.58% | 57.89% | 24.46% | -683.33% | -163.90% |
| Cash from Operations | 26.16% | 31.25% | 25.68% | 28.06% | 9.63% |
| Capital Expenditure | -- | -- | -845.45% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -845.45% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11.11% | -22.22% | -11.11% | -12.50% | -28.57% |
| Issuance of Common Stock | -- | -- | -- | -- | -84.00% |
| Repurchase of Common Stock | -20,600.00% | -20,600.00% | -20,600.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.72% | -101.50% | -100.74% | -100.71% | -84.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.17% | -23.83% | -561.75% | -486.60% | -399.20% |